SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Blankenship JC, Scott TD, Skelding KA, Haldis TA, Tompkins-Weber K, Sledgen MY, Donegan MA, Buckley JW, Sartorius JA, Hodgson JM, Berger PB. Door-to-balloon times under 90 min can be routinely achieved for patients transferred for ST-segment elevation myocardial infarction percutaneous coronary intervention in a rural setting. J Am Coll Cardiol 2011;57:272279.
  • 2
    Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:1320.
  • 3
    Henry TD, Sharkey SW, Burke MN, Chavez IJ, Graham KJ, Henry CR, Lips DL, Madison JD, Menssen KM, Mooney MR, Newell MC, Pedersen WR, Poulose AK, Traverse JH, Unger BT, Wang YL, Larson DM. A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation 2007; 116:721728.
  • 4
    Ting HH, Rihal CS, Gersh BJ, Haro LH, Bjerke CM, Lennon RJ, Lim CC, Bresnahan JF, Jaffe AS, Holmes DR, Bell MR. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: The Mayo Clinic STEMI Protocol. Circulation 2007;116:729736.
  • 5
    Zhang S, Ge J, Yao K, Qian J. Meta-analysis of early versus deferred revascularization for non-ST-segment elevation acute coronary syndrome. Am J Cardiol 2011;108:12071213.
  • 6
    Mehta SR, Cannon CP, Fox KA, Wallentin L, Boden WE, Spacek R, Widimsky P, McCullough PA, Hunt D, Braunwald E, Yusuf S. Routine vs selective invasive strategies in patients with acute coronary syndromes: A collaborative meta-analysis of randomized trials. JAMA 2005;293:29082917.
  • 7
    Chan PS, Patel MR, Klein LW, Krone RJ, Dehmer GJ, Kennedy K, Nallamothu BK, Weaver WD, Masoudi FA, Rumsfeld JS, Brindis RG, Spertus JA. Appropriateness of percutaneous coronary intervention. JAMA 2011;306:5361.
  • 8
    Strauss WE, Fortin T, Hartigan P, Folland ED, Parisi AF. A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy. Outcomes of a randomized clinical trial. Circulation 1995;92:17101719.
  • 9
    Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE, Mancini GB. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008;359:677687.
  • 10
    Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg D, Shurzinske L, McCormick LS. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med 1999;341:7076.
  • 11
    Hueb WA, Soares PR, Almeida De Oliveira S, Arie S, Cardoso RH, Wajsbrot DB, Cesar LA, Jatene AD, Ramires JA. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation 1999;100:107113.
  • 12
    Poses RM, Krueger JI, Sloman S, Elstein AS. Physicians' judgments of survival after medical management and mortality risk reduction due to revascularization procedures for patients with coronary artery disease. Chest 2002;122:122133.
  • 13
    Kee F, McDonald P, Gaffney B. Risks and benefits of coronary angioplasty: The patients perspective: A preliminary study. Qual Health Care 1997;6:131139.
  • 14
    Whittle J, Conigliaro J, Good CB, Kelley ME, Skanderson M. Understanding of the benefits of coronary revascularization procedures among patients who are offered such procedures. Am Heart J 2007;154:662668.
  • 15
    Rothberg MB, Sivalingam SK, Ashraf J, Visintainer P, Joelson J, Kleppel R, Vallurupalli N, Schweiger MJ. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med 2010;153:307313.
  • 16
    Holmboe ES, Fiellin DA, Cusanelli E, Remetz M, Krumholz HM. Perceptions of benefit and risk of patients undergoing first-time elective percutaneous coronary revascularization. J Gen Int Med 2000;15:632637.
  • 17
    Brindis R, Goldberg SD, Turco MA, Dean LS. President's page: Quality and appropriateness of care: The response to allegations and actions needed by the cardiovascular professional. J Am Coll Cardiol 2011;57:111113.
  • 18
    Gardner AW, Montgomery PS, Ritti-Dias RM, Thadani U. Exercise performance, physical activity, and health-related quality of life in participants with stable angina. Angiology 2011;62:461466.
  • 19
    Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58:e44122.
  • 20
    Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J 2010;31:25012555.
  • 21
    Campeau L. Letter: Grading of angina pectoris. Circulation 1976;54:522523.
  • 22
    Hlatky MA. Patient preferences and clinical guidelines. JAMA 1995;273:12191220.
  • 23
    Bliven BD, Green CP, Spertus JA. Review of available instruments and methods for assessing quality of life in anti-anginal trials. Drugs Aging 1998;13:311320.
  • 24
    Jofre R, Lopez-Gomez JM, Moreno F, Sanz-Guajardo D, Valderrabano F. Changes in quality of life after renal transplantation. Am J Kid Dis 1998;32:93100.
  • 25
    Franke GH, Reimer J, Philipp T, Heemann U. Aspects of quality of life through end-stage renal disease. Qual Life Res 2003;12:103115.
  • 26
    Ruckdeschel JC, Piantadosi S. Quality of life in lung cancer surgical adjuvant trials. Chest 1994;106:324S328S.
  • 27
    Buccheri GF, Ferrigno D, Tamburini M, Brunelli C. The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer 1995;12:4558.
  • 28
    Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am Vol 2004;86A:963974.
  • 29
    Fiebiger W, Mitterbauer C, Oberbauer R. Health-related quality of life outcomes after kidney transplantation. Health Qual Life Outcomes 2004;2:2.
  • 30
    Nilsdotter AK, Petersson IF, Roos EM, Lohmander LS. Predictors of patient relevant outcome after total hip replacement for osteoarthritis: A prospective study. Ann Rheum Dis 2003; 62:923930.
  • 31
    Russ G, Jamieson N, Oberbauer R, Arias M, Murgia MG, Blancho G, Sato R, Stoeckl M, Revicki DA. Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine. Transplant Int 2007;20:875883.
  • 32
    Pedersen SS, Versteeg H, Denollet J, Cheng JM, Serruys PW, van Domburg RT. Patient-rated health status predicts prognosis following percutaneous coronary intervention with drug-eluting stenting. Qual Life Res 2011;20:559567.
  • 33
    Schenkeveld L, Pedersen SS, van Nierop JW, Lenzen MJ, de Jaegere PP, Serruys PW, van Domburg RT. Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention. Am Heart J 2010; 159:471476.
  • 34
    Ferrans CE, Powers MJ. Quality of life index: Development and psychometric properties. Adv Nurs Sci 1985;8:1524.
  • 35
    Chambers LW, Sackett DL, Goldsmith CH, Macpherson AS, McAuley RG. 1993. The McMaster Health Index Questionnaire: An update. New York: Springer.
  • 36
    McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:4066.
  • 37
    Muller-Nordhorn J, Roll S, Willich SN. Comparison of the short form (SF)-12 health status instrument with the SF-36 in patients with coronary heart disease. Heart 2004;90:523527.
  • 38
    Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220233.
  • 39
    Hunt SM, McEwen J, McKenna SP. Measuring health status: A new tool for clinicians and epidemiologists. J R Coll Gen Pract 1985;35:185188.
  • 40
    Dupuy H. The Psychological General Well-being (PGWB) Index. Connecticut: Le Jacq; 1984.
  • 41
    Kaplan RM, Bush JW, Berry CC. Health status: Types of validity and the index of well-160.
  • 42
    Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS. The sickness impact profile: Validation of a health status measure. Med Care 1976;14:5767.
  • 43
    Brorsson B, Ifver J, Hays RD. The Swedish health-related quality of life survey (SWED-QUAL). Qual Life Res 1993;2:3345.
  • 44
    Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651654.
  • 45
    Valenti L, Lim L, Heller RF, Knapp J. An improved questionnaire for assessing quality of life after acute myocardial infarction. Qual Life Res 1996;5:151161.
  • 46
    Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn SD. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;25:333341.
  • 47
    Thompson DR, Jenkinson C, Roebuck A, Lewin RJ, Boyle RM, Chandola T. Development and validation of a short measure of health status for individuals with acute myocardial infarction: The myocardial infarction dimensional assessment scale (MIDAS). Qual Life Res 2002;11:535543.
  • 48
    Wilson A, Wiklund I, Lahti T, Wahl M. A summary index for the assessment of quality of life in angina pectoris. J Clin Epidemiol 1991;44:981988.
  • 49
    Mark DB, Hlatky MA. Medical economics and the assessment of value in cardiovascular medicine: Part I. Circulation 2002;106:516520.
  • 50
    Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:10951108.
  • 51
    Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Med Care 2005;43:203220.
  • 52
    Brorsson B, Bernstein SJ, Brook RH, Werko L. Quality of life of chronic stable angina patients 4 years after coronary angioplasty or coronary artery bypass surgery. J Intern Med 2001;249:4757.
  • 53
    Brown N, Melville M, Gray D, Young T, Munro J, Skene AM, Hampton JR. Quality of life four years after acute myocardial infarction: Short form 36 scores compared with a normal population. Heart 1999;81:352358.
  • 54
    Nash IS, Curtis LH, Rubin H. Predictors of patient-reported physical and mental health 6 months after percutaneous coronary revascularization. Am Heart J 1999;138:422429.
  • 55
    Pocock SJ, Henderson RA, Seed P, Treasure T, Hampton JR. Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3-year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation 1996;94:135142.
  • 56
    Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Fihn SD. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 1994;74:12401244.
  • 57
    Chen AY, Daley J, Thibault GE. Angina patients' ratings of current health and health without angina: Associations with severity of angina and comorbidity. Med Decis Making 1996;16:169177.
  • 58
    Pocock SJ, Henderson RA, Clayton T, Lyman GH, Chamberlain DA. Quality of life after coronary angioplasty or continued medical treatment for angina: Three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol 2000;35:907914.
  • 59
    Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673679.
  • 60
    Grines CL, Westerhausen DR,Jr, Grines LL, Hanlon JT, Logemann TL, Niemela M, Weaver WD, Graham M, Boura J, O'Neill WW, Balestrini C, Air PAMI Study G. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol 2002;39:17131719.
  • 61
    Widimsky P, Bilkova D, Penicka M, Novak M, Lanikova M, Porizka V, Groch L, Zelizko M, Budesinsky T, Aschermann M, PRAGUE Study Group I. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 Trial. Eur Heart J 2007;28:679684.
  • 62
    Zijlstra F, Hoorntje JC, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, van't Hof AW, Suryapranata H. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341:14131419.
  • 63
    Stone GW, Grines CL, Rothbaum D, Browne KF, O'Keefe J, Overlie PA, Donohue BC, Chelliah N, Vlietstra R, Catlin T, O'Neill WW. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: The Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol 1997;29:901907.
  • 64
    Morgan KP, Leahy M, Sheehy C, Eardley P, Shotter C, Beatt KJ. UK Primary Angioplasty Cost Effectiveness Study (UK-PACES) 30 Day Outcome Data. Heart 2005;91:A27.
  • 65
    Stone GW, Grines CL, Rothbaum D, Browne KF, O'Keefe J, Overlie PA, Donohue BC, Chelliah N, Vlietstra R, Catlin T, O'Neill WW. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: The Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol 1997;29:901907.
  • 66
    de Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoorntje JC, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol 1995;76:830833.
  • 67
    Rinfret S, Grines CL, Cosgrove RS, Ho KK, Cox DA, Brodie BR, Morice MC, Stone GW, Cohen DJ, Stent-PAMI I. Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial. J Am Coll Cardiol 2001;38:16141621.
  • 68
    Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos LA, Anderson HV, DeLucca PT, Mahoney EM, Murphy SA, Braunwald E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004;141:186195.
  • 69
    Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA 3 randomised trial. Randomized intervention trial of unstable Angina. Lancet 2002;360:743751.
  • 70
    Thrombolysis in Myocardial Ischemia Study Group. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in myocardial ischemia. Circulation 1994;89:15451556.
  • 71
    Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, Thompson B, Willerson JT, Braunwald E. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 1995; 26:16431650.
  • 72
    Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial. FRISC II Investigators. Fast revascularisation during instability in coronary artery disease. Lancet 2000;356:916.
  • 73
    Wong GC, Morrow DA, Murphy S, Kraimer N, Pai R, James D, Robertson DH, Demopoulos LA, DiBattiste P, Cannon CP, Gibson CM. Elevations in troponin T and I are associated with abnormal tissue level perfusion: A TACTICS-TIMI 18 substudy. Circulation 2002;106:202207.
  • 74
    Mortensen OS, Madsen JK, Haghfelt T, Grande P, Saunamaki K, Haunso S, Hjelms E, Arendrup H. Health related quality of life after conservative or invasive treatment of inducible postinfarction ischaemia. Heart 2000;84:535540.
  • 75
    Souza EN, Quadros AS, Maestri R, Albarrán C, Sarmento-Leite R. Preditores de mudança na qualidade de vida após um evento coronariano agudo (Predictors of quality of life change after an acute coronary event.). Arq Bras Cardiol 2008; 91:252259.
  • 76
    Kim J, Henderson RA, Pocock SJ, Clayton T, Sculpher MJ, Fox KA, RITA-3 Trial I. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: One-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3). J Am Coll Cardiol 2005;45:221228.
  • 77
    Pocock SJ, Henderson RA, Clayton T, Lyman GH, Chamberlain DA. Quality of life after coronary angioplasty or continued medical treatment for angina: Three-year follow-up in the RITA-2 trial. J Am Coll Cardiol 2000;35:907914.
  • 78
    Bliley AV, Ferrans CE. Quality of life after coronary angioplasty. Heart Lung 1993;22:193199.
  • 79
    McKenna KT, McEniery PT, Maas F, Aroney CN, Bett JH, Cameron J, Holt G, Hossack KF. Percutaneous transluminal coronary angioplasty: Clinical and quality of life outcomes one year later. Aust N Z J Med 1994;24:1521.
  • 80
    Permanyer-Miralda G, Alonso J, Brotons C, Cascant P, Ribera A, Moral I, Romero B, Domingo E, Anto JM, Soler-Soler J. Perceived health over 3 years after percutaneous coronary balloon angioplasty. J Clin Epidemiol 1999;52:615623.
  • 81
    Seto TB, Taira DA, Berezin R, Chauhan MS, Cutlip DE, Ho KK, Kuntz RE, Cohen DJ. Percutaneous coronary revascularization in elderly patients: Impact on functional status and quality of life. Ann Intern Med 2000;132:955958.
  • 82
    Spertus JA, Salisbury AC, Jones PG, Conaway DG, Thompson RC. Predictors of quality-of-life benefit after percutaneous coronary intervention. Circulation 2004;110:37893794.
  • 83
    Lowe HC, Oesterle SN, He KL, Macneill BD, Burkhoff D. Outcomes following percutaneous coronary intervention in patients previously considered “without option”: A subgroup analysis of the PACIFIC Trial. J Intervent Cardiol 2004;17:8791.
  • 84
    Wong MS, Chair SY. Changes in health-related quality of life following percutaneous coronary intervention: A longitudinal study. Int J Nurs Stud 2007;44:13341342.
  • 85
    Grantham JA, Jones PG, Cannon L, Spertus JA. Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia's approach to chronic total occlusion recanalization (FACTOR) trial. Circ Cardiovasc Qual Outcomes 2010;3:284290.
  • 86
    Melberg T, Nordrehaug JE, Nilsen DW. A comparison of the health status after percutaneous coronary intervention at a hospital with and without on-site cardiac surgical backup: A randomized trial in nonemergent patients. Euro J Cardiovasc Prevent Rehab 2010;17:235243.
  • 87
    de Quadros AS, Lima TC, Rodrigues AP, Modkovski TB, Welter DI, Sarmento-Leite R, Gottschall CA. Quality of life and health status after percutaneous coronary intervention in stable angina patients: Results from the real-world practice. Cathet Cardiovasc Intervent 2011;77:954960.
  • 88
    Borkon AM, Muehlebach GF, House J, Marso SP, Spertus JA. A comparison of the recovery of health status after percutaneous coronary intervention and coronary artery bypass. Ann Thorac Surg 2002;74:15261530.
  • 89
    Kattainen E, Sintonen H, Kettunen R, Merilainen P. Health-related quality of life of coronary artery bypass grafting and percutaneous transluminal coronary artery angioplasty patients: 1-year follow-up. Int J Technol Assess Health Care 2005; 21:172179.
  • 90
    Loponen P, Luther M, Korpilahti K, Wistbacka JO, Huhtala H, Laurikka J, Tarkka MR. HRQoL after coronary artery bypass grafting and percutaneous coronary intervention for stable angina. Scand Cardiovasc J 2009;43:9499.
  • 91
    van Domburg RT, Daemen J, Morice MC, de Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, van Es GA, Wittebols K, Macours N, Stoll HP, Serruys PW. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroIntervention 2010;5:962967.
  • 92
    Brooks MM, Chung SC, Helmy T, Hillegass WB, Escobedo J, Melsop KA, Massaro EM, McBane RD, Hyde P, Hlatky MA. Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the bypass angioplasty revascularization investigation 2 diabetes trial. Circulation 2010; 122:16901699.
  • 93
    Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: Outcomes for patients with double-vessel versus single-vessel coronary artery disease in a veterans affairs cooperative randomized trial. J Am Coll Cardiol 1997;29:15051511.
  • 94
    Favarato ME, Hueb W, Boden WE, Lopes N, Nogueira CR, Takiuti M, Gois AF, Borges JC, Favarato D, Aldrighi JM, Oliveira SA, Ramires JA. Quality of life in patients with symptomatic multivessel coronary artery disease: A comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial. Int J Cardiol 2007;116:364370.
  • 95
    Zhang Z, Kolm P, Boden WE, Hartigan PM, Maron DJ, Spertus JA, O'Rourke RA, Shaw LJ, Sedlis SP, Mancini GB, Berman DS, Dada M, Teo KK, Weintraub WS. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina. Circ Cardiovasc Qual Outcomes 2011;4:172182.
  • 96
    Wahrborg P. Quality of life after coronary angioplasty or bypass surgery. 1-year follow-up in the coronary angioplasty versus bypass revascularization investigation (CABRI) trial. Eur Heart J 1999;20:653658.
  • 97
    Zhang Z, Mahoney EM, Stables RH, Booth J, Nugara F, Spertus JA, Weintraub WS. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: One-year results from the Stent or Surgery trial. Circulation 2003;108:16941700.
  • 98
    Thiele H, Neumann-Schniedewind P, Jacobs S, Boudriot E, Walther T, Mohr FW, Schuler G, Falk V. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol 2009;53:23242331.
  • 99
    Cohen DJ, Van Hout B, Serruys PW, Mohr FW, Macaya C, den Heijer P, Vrakking MM, Wang K, Mahoney EM, Audi S, Leadley K, Dawkins KD, Kappetein AP. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med 2011;364:10161026.
  • 100
    Mark DB, Pan W, Clapp-Channing NE, Anstrom KJ, Ross JR, Fox RS, Devlin GP, Martin CE, Adlbrecht C, Cowper PA, Ray LD, Cohen EA, Lamas GA, Hochman JS. Quality of life after late invasive therapy for occluded arteries. N Engl J Med 2009;360:774783.
  • 101
    Brorsson B, Bernstein SJ, Brook RH, Werko L. Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population. Heart 2002;87:140145.
  • 102
    Hlatky MA, Boothroyd DB, Melsop KA, Brooks MM, Mark DB, Pitt B, Reeder GS, Rogers WJ, Ryan TJ, Whitlow PL, Wiens RD. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation 2004;110:19601966.
  • 103
    Krumholz HM, McHorney CA, Clark L, Levesque M, Baim DS, Goldman L. Changes in health after elective percutaneous coronary revascularization. A comparison of generic and specific measures. Med Care 1996;34:754759.
  • 104
    Kahler J, Lutke M, Weckmuller J, Koster R, Meinertz T, Hamm CW. Coronary angioplasty in octogenarians. Quality of life and costs. Eur Heart J 1999;20:17911798.
  • 105
    Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, Erbs S, Kluge R, Kendziorra K, Sabri O, Sick P, Schuler G. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: A randomized trial. Circulation 2004;109:13711378.
  • 106
    TIME I. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): A randomised trial. Lancet 2001;358:951957.
  • 107
    McKenna KT, McEniery PT, Maas F, Aroney CN, Bett JH, Cameron J, Garrahy P, Holt G, Hossack KF, Murphy AL. Clinical results and quality of life after percutaneous transluminal coronary angioplasty: A preliminary report. Cathet Cardiovasc Diagn 1992;27:8994.
  • 108
    Little T, Milner MR, Lee K, Constantine J, Pichard AD, Lindsay J Jr. Late outcome and quality of life following percutaneous transluminal coronary angioplasty in octogenarians. Cathet Cardiovasc Diagn 1993;29:261266.
  • 109
    Papadantonaki A, Stotts NA, Paul SM. Comparison of quality of life before and after coronary artery bypass surgery and percutaneous transluminal angioplasty. Heart Lung 1994;23:4552.
  • 110
    Faris JA, Stotts NA. The effect of percutaneous transluminal coronary angioplasty on quality of life. Prog Cardiovasc Nurs 1990;5:132140.
  • 111
    Jorgensen B, Simonsen S, Forfang K, Endresen K, Thaulow E. Effect of percutaneous transluminal coronary angioplasty on exercise in patients with and without previous myocardial infarction. Am J Cardiol 1998;82:10301033.
  • 112
    Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T. Estimating clinically significant differences in quality of life outcomes. Qual Life Res 2005;14:285295.
  • 113
    Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS, COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:15031516.
  • 114
    Henderson RA. Pocock SJ. Clayton TC. Knight R. Fox KA. Julian DG. Chamberlain DA; Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial: Coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003;42:11611170.
  • 115
    Dagenais GR, Lu J, Faxon DP, Kent K, Lago RM, Lezama C, Hueb W, Weiss M, Slater J. Frye RL. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation 2011;123:14921500.
  • 116
    Graham MM, Norris CM, Galbraith PD, Knudtson ML, Ghali WA, APPROACH I. Quality of life after coronary revascularization in the elderly. Eur Heart J 2006;27:16901698.
  • 117
    Norris CM, Saunders LD, Ghali WA, Brant R, Galbraith PD, Graham M, Faris P, Dzavik V, Knudtson ML, APPROACH I. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management. Can J Cardiol 2004;20:12591266.
  • 118
    Lukkarinen H, Hentinen M. Treatments of coronary artery disease improve quality of life in the long term. Nurs Res 2006;55:2633.
  • 119
    Benzer W, Hofer S, Oldridge NB. Health-related quality of life in patients with coronary artery disease after different treatments for angina in routine clinical practice. Herz 2003;28:421428.
  • 120
    Wijeysundera HC, Nallamothu BK, Krumholz HM, Tu JV, Ko DT. Meta-analysis: Effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med 2010;152:370379.
  • 121
    Brorsson B, Bernstein SJ, Brook RH, Werko L. Quality of life of chronic stable angina patients 4 years after coronary angioplasty or coronary artery bypass surgery. J Intern Med 2001;249:4757.
  • 122
    Lukkarinen H, Hentinen M. Assessment of quality of life with the Nottingham Health Profile among women with coronary artery disease. Heart Lung 1998;27:189199.
  • 123
    Hofer S, Doering S, Rumpold G, Oldridge N, Benzer W. Determinants of health-related quality of life in patients with coronary artery disease. Eur J Cardiovasc Prevent Rehab 2006;13:398406.
  • 124
    Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens R, Mark DB. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 1997;336:9299.
  • 125
    Federspiel JJ, Stearns SC, van Domburg RT, Sheridan BC, Lund JL, Serruys PW. Risk-benefit trade-offs in revascularisation choices. EuroIntervention 2011;6:936941.
  • 126
    Rumsfeld JS, Magid DJ, Plomondon ME, Sacks J, Henderson W, Hlatky M, Sethi G, Morrison DA; Department of Veterans Affairs Angina With Extremely Serious Operative Mortality (AWESOME) Investigators. Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. J Am Coll Cardiol 2003;41:17321738.
  • 127
    Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens R, Mark DB. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 1997;336:9299.
  • 128
    Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrie D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kahler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: A collaborative analysis of individual patient data from ten randomised trials. Lancet 2009;373:11901197.
  • 129
    Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, Varghese R, Kapoor JR, Ardehali R, Owens DK, Hlatky MA. Systematic review: The comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007;147:703716.
  • 130
    Szygula-Jurkewicz B, Wilczek K, Gorzkowska A, Niklewski T, Zembala M, Polonski L. 12-month outcomes of percutaneous and surgical revascularization in acute coronary syndromes without ST-segment elevation in patients with multivessel coronary artery disease. Pol Arch Med Wewn 2005;113:5662.
  • 131
    Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. JAMA 1997;277:715721.
  • 132
    Goy JJ, Kaufmann U, Goy-Eggenberger D, Garachemani A, Hurni M, Carrel T, Gaspardone A, Burnand B, Meier B, Versaci F, Tomai F, Bertel O, Pieper M, de Benedictis M, Eeckhout E. A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: The SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc 2000;75:11161123.
  • 133
    Rittger H, Rieber J, Kogler K, Sinha A, Schmidt M, Breithardt OA, Biggar P, Einsle F, Diegeler A, Brachmann J. Clinical outcome and quality of life after interventional treatment of left main disease with drug-eluting-stents in comparison to CABG in elderly and younger patients. Clin Res Cardiol 2011;100:439446.
  • 134
    Cameron J, Mahanonda N, Aroney C, Hayes J, McEniery P, Gardner M, Bett N. Outcome five years after percutaneous transluminal coronary angioplasty or coronary artery bypass grafting for significant narrowing limited to the left anterior descending coronary artery. Am J Cardiol 1994;74:544549.
  • 135
    Zhang Z, Weintraub WS, Mahoney EM, Spertus JA, Booth J, Nugara F, Stables RH, Vaccarino V. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial). Am J Cardiol 2004;93:404409.
  • 136
    Mortensen OS, Bjorner JB, Newman B, Oldenburg B, Groenvold M, Madsen JK, Andersen HR, DANAMI-2 Study G. Gender differences in health-related quality of life following ST-elevation myocardial infarction: Women and men do not benefit from primary percutaneous coronary intervention to the same degree. Eur J Cardiovasc Prevent Rehab 2007;14:3743.
  • 137
    Holubkov R, Laskey WK, Haviland A, Slater JC, Bourassa MG, Vlachos HA, Cohen HA, Williams DO, Kelsey SF, Detre KM, NHLBI Dynamic Registry Investigators. Angina 1 year after percutaneous coronary intervention: A report from the NHLBI Dynamic Registry. Am Heart J 2002;144:826833.
  • 138
    Ladwig KH, Muhlberger N, Walter H, Schumacher K, Popp K, Holle R, Zitzmann-Roth E, Schomig A. Gender differences in emotional disability and negative health perception in cardiac patients 6 months after stent implantation. J Psychosom Res 2000;48:501508.
  • 139
    Pfisterer M, Buser P, Osswald S, Allemann U, Amann W, Angehrn W, Eeckhout E, Erne P, Estlinbaum W, Kuster G, Moccetti T, Naegeli B, Rickenbacher P. Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: One-year results of the randomized TIME trial. JAMA 2003;289:11171123.
  • 140
    Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: Four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation 2004;110:12131218.
  • 141
    Chait R, Zad O, Ramineni R, Shukla A, Mitchell A. Midterm outcomes and quality of life following percutaneous coronary intervention in nonagenarians. Am J Cardiol 2011;107:16091612.
  • 142
    Bundhoo SS, Kalla M, Anantharaman R, Morris K, Chase A, Smith D, Anderson RA, Kinnaird TD. Outcomes following PCI in patients with previous CABG: A multi centre experience. Cathet Cardiovasc Intervent 2011;78:169176.
  • 143
    Hawkes AL, Mortensen OS. Up to one third of individual cardiac patients have a decline in quality of life post-intervention. Scand Cardiovasc J 2006;40:214218.
  • 144
    Taira DA, Seto TB, Ho KK, Krumholz HM, Cutlip DE, Berezin R, Kuntz RE, Cohen DJ. Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation 2000;102:13691374.
  • 145
    Bourassa MG, Brooks MM, Mark DB, Trudel J, Detre KM, Pitt B, Reeder GS, Rogers WJ, Ryan TJ, Smith HC, Whitlow PL, Wiens RD, Hlatky MA. Quality of life after coronary revascularization in the United States and Canada. Am J Cardiol 2000;85:548553.
  • 146
    Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training intervention after coronary angioplasty: The ETICA trial. J Am Coll Cardiol 2001;37:18911900.
  • 147
    Higgins HC, Hayes RL, McKenna KT. Rehabilitation outcomes following percutaneous coronary interventions (PCI). Patient Ed Counsel 2001;43:219230.
  • 148
    Brorsson B, Bernstein SJ, Brook RH, Werko L. Quality of life of chronic stable angina patients 4 years after coronary angioplasty or coronary artery bypass surgery. J Intern Med 2001;249:4757.
  • 149
    Jamieson M, Wilcox S, Webster W, Blackhurst D, Valois RF, Durstine JL. Factors influencing health-related quality of life in cardiac rehabilitation patients. Prog Cardiovasc Nurs 2002;17:124131.
  • 150
    Haddock CK, Poston WS, Taylor JE, Conard M, Spertus J. Smoking and health outcomes after percutaneous coronary intervention. Am Heart J 2003;145:652657.
  • 151
    Hlatky MA, Boothroyd DB, Melsop KA, Brooks MM, Mark DB, Pitt B, Reeder GS, Rogers WJ, Ryan TJ, Whitlow PL, Wiens RD. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. Circulation 2004;110:19601966.
  • 152
    Spertus JA, Nerella R, Kettlekamp R, House J, Marso S, Borkon AM, Rumsfeld JS. Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery. Circulation 2005;111:768773.
  • 153
    Denvir MA, Lee AJ, Rysdale J, Walker A, Eteiba H, Starkey IR, Pell JP. Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention. J Epidemiol Community Health 2006;60:10851088.
  • 154
    Leslie SJ, Rysdale J, Lee AJ, Eteiba H, Starkey IR, Pell J, Denvir MA. Unemployment and deprivation are associated with a poorer outcome following percutaneous coronary angioplasty. Int J Cardiol 2007;122:168169.
  • 155
    Kriston L, Gunzler C, Agyemang A, Bengel J, Berner MM, SPARK Study G. Effect of sexual function on health-related quality of life mediated by depressive symptoms in cardiac rehabilitation. findings of the SPARK project in 493 patients. J Sex Med 2010;7:20442055.
  • 156
    Rittger H, Rieber J, Kogler K, Sinha A, Schmidt M, Breithardt OA, Biggar P, Einsle F, Diegeler A, Brachmann J. Clinical outcome and quality of life after interventional treatment of left main disease with drug-eluting-stents in comparison to CABG in elderly and younger patients. Clin Res Cardiol 2011;100:439446.
  • 157
    Simoons ML, Windecker S. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: Drugs vs. revascularization. Eur Heart J 2010;31:530541.
  • 158
    Melsop KA, Boothroyd DB, Hlatky MA. Quality of life and time trade-off utility measures in patients with coronary artery disease. Am Heart J 2003;145:3641.
  • 159
    Skaggs BG, Yates BC. Quality of life comparisons after coronary angioplasty and coronary artery bypass graft surgery. Heart Lung 1999;28:409417.
  • 160
    Groeneveld PW, Suh JJ, Matta MA. The costs and quality-of-life outcomes of drug-eluting coronary stents: A systematic review. J Interv Cardiol 2007;20:19.
  • 161
    Ploegmakers MM, Viscaal AM, Finch L, Mayo NE, Brophy JM. The disutility of restenosis--the impact of repeat percutaneous coronary intervention on quality of life. Can J Cardiol 2010;26:197200.
  • 162
    Jamieson M, Wilcox S, Webster W, Blackhurst D, Valois RF, Durstine JL. Factors influencing health-related quality of life in cardiac rehabilitation patients. Prog Cardiovasc Nurs 2002;17:124131.
  • 163
    El-Sakka AI, Morsy AM, Fagih BI, Nassar AH. Coronary artery risk factors in patients with erectile dysfunction. J Urol 2004;172:251254.
  • 164
    Lukkarinen H, Lukkarinen O. Sexual satisfaction among patients after coronary bypass surgery or percutaneous transluminal angioplasty: Eight-year follow-up. Heart Lung 2007;36:262269.
  • 165
    Levine GN, Steinke EE, Bakaeen FG, Bozkurt B, Cheitlin MD, Conti JB, Foster E, Jaarsma T, Kloner RA, Lange RA, Lindau ST, Maron BJ, Moser DK, Ohman EM, Seftel AD, Stewart WJ. Sexual activity and cardiovasacular disease: A scientific statement from the American Heart Association. Circulation 2012;125:10581072.
  • 166
    Beauchamp TL, Childress JF. Principles of Biomedical Ethics. Oxford University Press; 1989.
  • 167
    Paterick TJ, Carson GV, Allen MC, Paterick TE. Medical informed consent: General considerations for physicians. Mayo Clin Proc 2008;83:313319.
  • 168
    Critchfield TS, Kollins SH. Temporal discounting: Basic research and the analysis of socially important behavior. J Appl Behav Anal 2001;34:101122.
  • 169
    Holmboe ES, Fiellin DA, Cusanelli E, Remetz M, Krumholz HM. Perceptions of benefit and risk of patients undergoing first-time elective percutaneous coronary revascularization. J Gen Intern Med 2000;15:632637.
  • 170
    Feinstein AR. The “chagrin factor” and qualitative decision analysis. Arch Intern Med 1985;145:12571259.